Type
. Social stigma as an epidemiological determinant for leprosy elimination in Cameroon. Journal of public health in Africa [Internet]. 2011;2(1):e10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345469/pdf/jphia-2011-1-e10.pdf
Type
. Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity. The FEBS journal. 2017;.
Type
. Monitoring impairment in leprosy: choosing the appropriate tool. Leprosy review [Internet]. 2007;78(3):270-80. Available from: https://leprosyreview.org/article/78/3/27-0280
Type
. Leprosy in Colombia: post elimination stage?. Leprosy review [Internet]. 2013;84(3):238-47. Available from: https://leprosyreview.org/article/84/3/23-8247
Type
. Leprosy situation in Nigeria. Leprosy review [Internet]. 2013;84(3):229-37. Available from: https://leprosyreview.org/article/84/3/22-9237
Type
. The prevention of leprosy related disability as an integral component of the government health delivery programme in Indonesia: perspectives on implementation. Leprosy review [Internet]. 2013;84(3):219-28. Available from: https://leprosyreview.org/article/84/3/21-9228
Type
. Enhancing counselling strategies for leprosy patients through the participation scale. Leprosy review [Internet]. 2013;84(3):199-208. Available from: https://leprosyreview.org/article/84/3/19-9208
Type
. Peroneal strength as an indicator in selecting route of tibialis posterior transfer for foot drop correction in leprosy. Leprosy review [Internet]. 2013;84(3):186-93. Available from: https://leprosyreview.org/article/84/3/18-6193
Type
. Intolerance to leprosy multi-drug therapy: more common in women?. Leprosy review [Internet]. 2013;84(3):209-18. Available from: https://leprosyreview.org/article/84/3/20-9218
Type
. Lepromatous Neuropathy. Korean Leprosy Bulletin. 2001;34(1):13-24.